tiprankstipranks
Trending News
More News >
Viva Biotech Holdings (HK:1873)
:1873
Hong Kong Market

Viva Biotech Holdings (1873) Income Statement

Compare
3 Followers

Viva Biotech Holdings Income Statement

Last quarter (Q2 2025), Viva Biotech Holdings's total revenue was ¥831.87M, a decrease of -27.17% from the same quarter last year. In Q2, Viva Biotech Holdings's net income was ¥121.81M. See Viva Biotech Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.99B¥ 2.16B¥ 2.38B¥ 2.10B¥ 696.96M
Gross Profit
¥ 687.40M¥ 738.43M¥ 815.68M¥ 650.98M¥ 304.87M
Operating Expenses
¥ 457.73M¥ 545.75M¥ 546.33M¥ 414.08M¥ 189.30M
Depreciation and Amortization
¥ 198.33M¥ 198.33M¥ 170.37M¥ 133.04M¥ 51.81M
EBITDA
¥ 428.00M¥ 391.01M¥ 436.35M¥ 369.94M¥ 164.35M
Operating Income
¥ 229.67M¥ 192.68M¥ 269.35M¥ 236.90M¥ 115.57M
Other Income/Expenses
¥ 66.04M¥ -248.64M¥ -728.51M¥ 110.80M¥ -471.78M
Pretax Income
¥ 295.70M¥ -55.95M¥ -459.17M¥ 347.70M¥ -356.21M
Net Income
¥ 167.29M¥ -116.11M¥ -528.48M¥ 287.55M¥ -386.88M
Per Share Metrics
Basic EPS
¥ 0.08¥ -0.06¥ -0.28¥ 0.15¥ -0.25
Diluted EPS
¥ 0.06¥ -0.06¥ -0.28¥ 0.15¥ -0.25
Weighted Average Shares Outstanding
2.14B 1.94B 1.89B 1.91B 1.55B
Weighted Average Shares Outstanding (Diluted)
2.87B 2.03B 1.92B 1.97B 1.57B
Currency in CNY

Viva Biotech Holdings Earnings and Revenue History